MAPK3, mitogen-activated protein kinase 3, 5595

N. diseases: 647; N. variants: 7
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0024121
Disease: Lung Neoplasms
Lung Neoplasms
0.340 Biomarker group BEFREE Anti-PD1 antibody led to a significant decrease in the number of OS lung metastases, enhanced tumor apoptosis, decreased tumor cell proliferation, and p-STAT-3/p-Erk1/2 signaling blockade in OS lung tumors. 29733528 2018
CUI: C0024121
Disease: Lung Neoplasms
Lung Neoplasms
0.340 Biomarker group BEFREE By the nanoimmunoassay (NIA), KRAS is found to activate the protein ERK2, whereas ERK1 activation is found in non-KRAS-associated human lung tumors. 28400509 2017
CUI: C0024121
Disease: Lung Neoplasms
Lung Neoplasms
0.340 Biomarker group BEFREE In addition, COL6 was capable of stimulating signaling pathways that activate focal adhesion kinase and extracellular signal‑regulated kinase 1/2 in lung epithelial cells, which may also facilitate the development of lung neoplasms. 25176343 2014
CUI: C0024121
Disease: Lung Neoplasms
Lung Neoplasms
0.340 Biomarker group BEFREE These experiments provide the first evidence that inhibition of p-AKT and induction of p-ERK1/2 are crucial events in the induction of TIMP-3-mediated endothelial apoptosis in MMP-2 inhibited lung tumors. 18559520 2008
CUI: C0024121
Disease: Lung Neoplasms
Lung Neoplasms
0.340 Biomarker group CTD_human Vanadium increases GLUT4 in diabetic rat skeletal muscle. 12083368 2002
CUI: C0024121
Disease: Lung Neoplasms
Lung Neoplasms
0.340 Biomarker group CTD_human Levels of K-ras p21, raf-1, mitogen-activated protein kinases Erk 1 and 2, the phosphorylated-activated forms of Erk 1 and 2 (Erk 1P and 2P), and proliferating cell nuclear antigen (PCNA) were measured by immunoblotting in mouse lung tumors (5 to 9 mm in size) caused by N-nitrosodimethylamine (NDMA) and in control lungs. 11884234 2002